CERO THERAPEUTICS HOLDINGS, INC. Proceeds from Collection of Notes Receivable
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Proceeds from Collection of Notes Receivable of $4.20 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2025-11-19
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from collection of notes receivable for the quarter ending 2025-09-30 was $1.30M.
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from collection of notes receivable for the quarter ending 2025-06-30 was $500.00K.
- CERO THERAPEUTICS HOLDINGS, INC. proceeds from collection of notes receivable for the quarter ending 2025-03-31 was $2.40M.
| Period end | Proceeds from Collection of Notes Receivable 3 month | Proceeds from Collection of Notes Receivable 6 month | Proceeds from Collection of Notes Receivable 9 month |
|---|---|---|---|
| 2025-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $1.80M derived: sum of 2 quarters · filed 2025-11-19 | $4.20M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-22 | $2.90M 10-Q · filed 2025-08-22 | |
| 2025-03-31 | $2.40M 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |